Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Ready to take control of your GLP-1 spend and enhance member outcomes
Researchers are still exploring the full extent of these brain effects, but the impact on appetite control is a key part of how these medications aid in weight management
By Product: Ozempic dominates, Tirzepatide products growing fastest Ozempic (semaglutide 0.5mg/1mg/2mg weekly subcutaneous injection) dominated the GLP-1 receptor agonist market with approximately 35.12% market share in 2025, driven by its combination of robust clinical efficacy data, early market entry, broad diabetes label, established prescriber relationships, and expanded off-label use for weight management before Wegovy's commercial scale-up
You're correct
The Pfam database, the Interpro tool, and the SMART database were utilized to verify the domains presence in all GST genes
US$ 28.70
US$ 29.36
US$ 27.83
US$ 27.38
US$ 20.33
US$ 27.39
US$ 22.50
US$ 27.26
US$ 20.63
US$ 25.45
US$ 26.70
US$ 28.60
